Farah Al Haj, Mina Abdelmalek, Jayastu Senapati, Guillermo Montalban-Bravo, Stefan Faderl, William D. Marrero, Nicholas Short, Naval Daver, Courtney DiNardo, Lucia Masarova, Alessandra Ferrajoli, Elias Jabbour, Gautam Borthakur, Guillermo Garcia-Manero, Michael Andreeff, Tapan Kadia, Farhad Ravandi, Yesid Alvarado Valero. "Combination of CPX-351 and gemtuzumab ozogamicin (GO) in relapsed/refractory (R/R) Acute Myeloid Leukemia and post-hypomethylating agent (HMA) failure high-risk myelodysplastic syndrome (HR-MDS)." Blood, 2025. doi:10.1182/blood-2025-1688